​
Login / Signup
Huandi Zhou
ORCID
Publication Activity (10 Years)
Years Active: 2021-2022
Publications (10 Years): 5
Top Topics
Dna Damage Response
Diabetic Nephropathy
Crispr Cas
Reactive Oxygen Species
Top Venues
BioMed research international
Disease markers
Journal of oncology
International journal of endocrinology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Huandi Zhou
,
Zhifen Yang
,
Lin Mu
,
Yonghong Shi
Integrated Analysis of Multiple Microarray Studies to Identify Core Gene-Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy.
BioMed research international
2022 (2022)
Lin Mu
,
Nan Chen
,
Yakun Chen
,
Zhifen Yang
,
Huandi Zhou
,
Shan Song
,
Yonghong Shi
Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress.
International journal of endocrinology
2022 (2022)
Liubing Hou
,
Huandi Zhou
,
Yanqiang Wang
,
Junling Liu
,
Dongdong Zhang
,
Yuehong Li
,
Xiaoying Xue
Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma.
Disease markers
2022 (2022)
Qi Gao
,
Huandi Zhou
,
Guohui Wang
,
Zhenghui Ma
,
Jiayuan Li
,
Hong Wang
,
Guo-Zhu Sun
,
Xiaoying Xue
A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 Glioma.
Journal of oncology
2022 (2022)
Huandi Zhou
,
Le Jiang
,
Guohui Wang
,
Linlin Su
,
Liubing Hou
,
Xiaoying Xue
Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma.
BioMed research international
2021 (2021)